摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

辛基酚聚醚-3 | 2315-67-5

中文名称
辛基酚聚醚-3
中文别名
辛基酚聚醚-5
英文名称
2-[4-(2,4,4-trimethylpentan-2-yl)phenoxy]ethanol
英文别名
2-ethanol;2-[p-(1',1',3',3'-tetramethylbutyl)phenoxy]ethanol;2-[4-(1,1,3,3-tetramethylbutyl)phenoxy]ethanol;4-t-octylphenolmonoethoxylate;Triton-X-100;triton x-100
辛基酚聚醚-3化学式
CAS
2315-67-5;63869-93-2
化学式
C16H26O2
mdl
MFCD00214058
分子量
250.381
InChiKey
JYCQQPHGFMYQCF-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    351.2±25.0 °C(Predicted)
  • 密度:
    0.980-0.990 g/cm3(Temp: 25 °C)
  • 闪点:
    -17℃
  • 溶解度:
    可溶于氯仿(少许)、甲醇(少许)
  • LogP:
    4.992 (est)

计算性质

  • 辛醇/水分配系数(LogP):
    4.6
  • 重原子数:
    18
  • 可旋转键数:
    6
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.625
  • 拓扑面积:
    29.5
  • 氢给体数:
    1
  • 氢受体数:
    2

安全信息

  • 危险品标志:
    F,Xi
  • 安全说明:
    S16,S26,S61,S9
  • 危险类别码:
    R11,R36,R52/53,R66,R67
  • WGK Germany:
    1
  • 海关编码:
    2909499000

SDS

SDS:ba869b6025e208aa612887ffeba772d5
查看

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    辛基酚聚醚-3三乙胺三氯氧磷 作用下, 以 四氢呋喃 为溶剂, 生成 1-(2-Dichlorophosphoryloxyethoxy)-4-(2,4,4-trimethylpentan-2-yl)benzene
    参考文献:
    名称:
    Synthesis, self-aggregation and biological properties of alkylphosphocholine and alkylphosphohomocholine derivatives of cetyltrimethylammonium bromide, cetylpyridinium bromide, benzalkonium bromide (C16) and benzethonium chloride
    摘要:
    A series of alkylphosphocholine and alkylphosphohomocholine derivatives of cetyltrimethylammonium bromide, cetylpyridinium bromide, benzalkonium bromide (C16) and benzethonium chloride have been synthesized. Their physicochemical properties were also investigated. The critical micelle concentration (cmc), the surface tension value at the cmc (gamma(cmc)) and the surface area at the surface saturation per head group (A(cmc)) were determined by means of surface tension measurements. The prepared compounds exhibit significant cytotoxic, antifungal and antiprotozoal activities. Alkylphosphocholines and alkylphosphohomocholines possess higher antifungal activity against Candida albicans in comparison with quaternary ammonium compounds in general. However, quaternary ammonium compounds exhibit significantly higher activity against human tumor cells and pathogenic free-living amoebae Acanthamoeba lugdunensis and Acanthamoeba quina compared to alkylphosphocholines. The relationship between structure, physicochemical properties and biological activity of the tested compounds is discussed. (C) 2013 Elsevier Masson SAS. All rights reserved.
    DOI:
    10.1016/j.ejmech.2013.05.033
  • 作为产物:
    描述:
    1,1,3,3-tetramethylbutylphenolate sodium 在 lithium aluminium tetrahydride 作用下, 以 四氢呋喃二甲基亚砜 为溶剂, 生成 辛基酚聚醚-3
    参考文献:
    名称:
    Isolation of Bacterial Strains that Produce the Endocrine Disruptor, Octylphenol Diethoxylates, in Paddy Fields
    摘要:
    从日本西部的36个不同水稻田收集了表层土壤样本。每个土壤样本都跟含有0.2% OPPEO的基础盐培养基一起孵育。十二个样本表现出OPPEO降解活性,分别从中分离出十二种OPPEO降解细菌。所分离的细菌在含有0.2% OPPEO作为唯一碳源的培养基上生长,在好氧条件下积累了OP2EO和OP3EO。在本实验中,通常与OP2EO一起在地表水中被识别的OP1EO和辛基酚并未被观察到。通过BIOLOG和16S rDNA RFLP分析,所分离的细菌为革兰氏阴性,初步鉴定为假单胞菌(Pseudomonas putida,10个分离株)和伯克霍尔德菌(Burkholderia cepacia,一个分离株)。
    DOI:
    10.1271/bbb.66.1792
  • 作为试剂:
    描述:
    1-diazo-1-ethyl-butanone 、 二氨基马来腈辛基酚聚醚-3 作用下, 以 为溶剂, 生成 5,6-diethylpyrazine-2,3-dicarbonitrile
    参考文献:
    名称:
    B7 Induces Apoptosis in Colorectal Cancer Cells by Regulating the Expression of Caspase-3 and Inhibits Autophagy
    摘要:
    DOI:
    10.2147/ott.s429128
点击查看最新优质反应信息

文献信息

  • Solvent Extraction of Trivalent Yttrium, Holmium, and Erbium by Novel Types of Acidic Organophosphonates
    作者:Keisuke Ohto、Katsutoshi Inoue、Masahiro Goto、Fumiyuki Nakashio、Takeshi Nagasaki、Seiji Shinkai、Tokihiro Kago
    DOI:10.1246/bcsj.66.2528
    日期:1993.9
    New types of acidic organophosphonates, HR with different hydrophobic groups, were synthesized in order to investigate their extraction behavior for heavy rare earth elements (Y3+, Ho3+, and Er3+) from aqueous acidic chloride media. Their physicochemical properties, such as aggregation in an organic diluent and the acid dissociation constants (Ka) in the aqueous phase, were also examined. These rare earth elements were supposed to be extracted according to the stoichiometric relation,This idea and the extraction equilibrium constants (Kex) for each metal ion were evaluated. Both the extraction equilibrium constants and the separation factors (β) between these metal ions were found to be greater than those of commercial extractants. The correlation between the extractability of heavy rare earth elements, the selectivity among these elements and the chemical structures of these extractants are discussed from a qualitative perspective.
    为研究新型酸性有机膦酸酯HR(含不同疏水基团)从水溶液酸性氯化物介质中提取重稀土元素(Y3+、Ho3+和Er3+)的行为,对其进行了合成研究。同时考察了这些萃取剂的理化性质,如有机稀释剂中的聚集现象和水相中的酸离解常数(Ka)。据推测,这些稀土元素的提取遵循化学计量关系,并评估了这一假设及各金属离子的萃取平衡常数(Kex)。结果显示,相比于商业萃取剂,这些萃取剂的萃取平衡常数和金属离子间的分离因子(β)均更大。本文从定性角度探讨了重稀土元素的萃取性能、元素间的选择性以及萃取剂化学结构间的相关关系。
  • [EN] COMPOUNDS AND COMPOSITIONS FOR COGNITION-ENHANCEMENT, METHODS OF MAKING, AND METHODS OF TREATING<br/>[FR] COMPOSÉS ET COMPOSITIONS POUR AMÉLIORER LA FONCTION COGNITIVE, PROCÉDÉS DE FABRICATION ET MÉTHODES DE TRAITEMENT
    申请人:MITHRIDION INC
    公开号:WO2010102218A1
    公开(公告)日:2010-09-10
    Muscarinic agonists, which are useful for stimulating muscarinic receptors and treating cognitive disorders, are provided. Methods of synthesizing such agonists also are provided. Also provided are compositions for enhancing cognitive function in subjects such as humans, the compositions comprising a muscarinic agonist or a pharmaceutically suitable form thereof. Also provided are methods of treating animals such as humans by administering such compositions.
    提供了用于刺激肌气受体并治疗认知障碍的肌气受体激动剂。还提供了合成这类激动剂的方法。还提供了用于增强人类等受试者认知功能的组合物,该组合物包括肌气受体激动剂或其药用适宜形式。还提供了通过给予这类组合物来治疗动物如人类的方法。
  • NOVEL PHOSPHATIDYLALKANOLS AND COMPOSITIONS THEREOF
    申请人:PETHMARK AB
    公开号:US20160052946A1
    公开(公告)日:2016-02-25
    The present invention discloses a composition comprising a compound of formula I and a deuterated solvent. The deuterated solvent is miscible with water in any proportion at a temperature of 20 to 25° C. and comprises less than 5% residual 1 H-isotopes. The concentration of the compound of formula I may advantageously be determined by 1 H-QNMR. Methods of production of the composition and salts of compounds of formula I, as well as related analogs and novel reagents and intermediates for the production thereof, are also described.
    本发明揭示了一种包含式I化合物和氘化溶剂的组合物。氘化溶剂在20至25°C温度下与水可任意比例混合,并且含有少于5%的残留1H同位素。化合物式I的浓度可优选通过1H-QNMR确定。还描述了该组合物的生产方法、式I化合物的盐、以及相关类似物和新型试剂和中间体的生产方法。
  • [EN] COMPOUNDS AND COMPOSITIONS FOR COGNITION-ENHANCEMENT, METHODS OF MAKING, AND METHODS OF TREATING<br/>[FR] COMPOSÉS ET COMPOSITIONS POUR L'AMÉLIORATION DE LA COGNITION, LEURS PROCÉDÉS DE FABRICATION, ET MÉTHODES DE TRAITEMENT
    申请人:MITHRIDION INC
    公开号:WO2011085406A1
    公开(公告)日:2011-07-14
    Disclosed are muscarinic agonist compounds including oxadiazole derivatives, compositions and preparations thereof. Also disclosed are methods of synthesizing such oxadiazole compounds. Further disclosed are methods for treating a subject with said muscarinic agonists or a pharmaceutically suitable form thereof to enhance cognitive function.
    揭示了包括噻唑二唑衍生物在内的肌碱激动剂化合物,以及其组合物和制剂。还揭示了合成这种噻唑二唑化合物的方法。进一步揭示了使用这些肌碱激动剂或其药学适宜形式来增强认知功能的治疗方法。
  • SUSTAINED DELIVERY OF ANGIOPOETIN-LIKE 3 POLYPEPTIDES
    申请人:NOVARTIS AG
    公开号:US20200108153A1
    公开(公告)日:2020-04-09
    Described herein are drug delivery systems for delivering biologically active agents comprising primary or secondary amines, or a ring nitrogen atom of an azaheteroaryl ring, pharmaceutically acceptable salts thereof, drug delivery reagents related thereto, pharmaceutical compositions comprising the drug delivery systems, and the use of the drug delivery systems as sustained release therapeutics.
    本文描述了用于传递生物活性剂的药物传递系统,包括主要或次要胺,或者是氮杂杂环环的环氮原子,其药用盐,相关的药物传递试剂,包括药物传递系统的制药组合物,以及将药物传递系统用作持续释放治疗的用途。
查看更多

表征谱图

  • 氢谱
    1HNMR
  • 质谱
    MS
  • 碳谱
    13CNMR
  • 红外
    IR
  • 拉曼
    Raman
查看更多图谱数据,请前往“摩熵化学”平台
查看更多图谱数据,请前往“摩熵化学”平台
查看更多图谱数据,请前往“摩熵化学”平台
ir
查看更多图谱数据,请前往“摩熵化学”平台
  • 峰位数据
  • 峰位匹配
  • 表征信息
Shift(ppm)
Intensity
查看更多图谱数据,请前往“摩熵化学”平台
Assign
Shift(ppm)
查看更多图谱数据,请前往“摩熵化学”平台
测试频率
样品用量
溶剂
溶剂用量
查看更多图谱数据,请前往“摩熵化学”平台

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫 龙胆紫 齐达帕胺 齐诺康唑 齐洛呋胺 齐墩果-12-烯[2,3-c][1,2,5]恶二唑-28-酸苯甲酯 齐培丙醇 齐咪苯 齐仑太尔 黑染料 黄酮,5-氨基-6-羟基-(5CI) 黄酮,6-氨基-3-羟基-(6CI) 黄蜡,合成物 黄草灵钾盐